Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SIEMENS HEALTHINEERS AG

(SHL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Siemens Healthineers : CMD Segment Presentation – Nov 17, 2021

11/17/2021 | 02:07am EST

Capital Markets Day 2021

Segment Presentations

André Hartung, President Diagnostic Imaging Deepak Nath, President Laboratory Diagnostics

Chris Toth, CEO Varian - A Siemens Healthineers Company Carsten Bertram, President Advanced Therapies

November 17, 2021

Unrestricted © Siemens Healthineers, 2021

Safe harbor statement

This presentation has been prepared solely for use at this meeting. This material is given in conjunction with an oral presentation and should not be taken out of context. By attending the meeting where this presentation is held or accessing this presentation, you agree to be bound by the following limitations.

This presentation has been prepared for information purposes only and the information contained herein (unless otherwise indicated) has been provided by Siemens Healthineers AG. It does not constitute or form part of, and should not be construed as, an offer of, a solicitation of an offer to buy, or an invitation to subscribe for, underwrite or otherwise acquire, any securities of Siemens Healthineers AG or any existing or future member of the Siemens Healthineers Group (the "Group") or Siemens AG, nor should it or any part of it form the basis of, or be relied on in connection with, any contract to purchase or subscribe for any securities of Siemens Healthineers AG, any member of the Group or Siemens AG or with any other contract or commitment whatsoever. This presentation does not constitute a prospectus in whole or in part, and any decision to invest in securities should be made solely on the basis of the information to be contained in a prospectus and on an independent analysis of the information contained therein.

Any assumptions, views or opinions (including statements, projections, forecasts or other forward-looking statements) contained in this presentation represent the assumptions, views or opinions of Siemens Healthineers AG, unless otherwise indicated, as of the date indicated and are subject to change without notice.

Siemens Healthineers neither intends, nor assumes any obligation, unless required by law, to update or revise these assumptions, views or opinions in light of developments which differ from those anticipated.

All information not separately sourced is from internal company data and estimates. Any data relating to past performance contained herein is no indication as to future performance. The information in this presentation is not intended to predict actual results, and no assurances are given with respect thereto.

The information contained in this presentation has not been independently verified, and no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information contained herein and no reliance should be placed on it. None of Siemens Healthineers AG or any of its affiliates, advisers, affiliated persons or any other person accept any liability for any loss howsoever arising (in negligence or otherwise), directly or indirectly, from this presentation or its contents or otherwise arising in connection with this presentation. This shall not, however, restrict or exclude or limit any duty or liability to a person under any applicable law or regulation of any jurisdiction which may not lawfully be disclaimed (including in relation to fraudulent misrepresentation).

This document contains statements related to our future business and financial performance and future events or developments involving Siemens Healthineers that may constitute forward-looking statements. These statements may be identified by words such as "expect", "forecast", "anticipate", "intend", "plan", "believe", "seek", "estimate", "will", "target" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to shareholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens Healthineers' management, of which many are beyond Siemens Healthineers' control. As they relate to future events or developments, these statements are subject to a number of risks, uncertainties and factors, including, but not limited to those described in the respective disclosures. Should one or more of these risks, uncertainties or factors materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Siemens Healthineers may (negatively or positively) vary materially from those described explicitly or implicitly in the forward-looking statement.

This document includes supplemental financial measures that are or may be alternative performance measures not precisely defined in the applicable financial reporting framework (non-GAAP measures). These supplemental financial measures may have limitations as analytical tools and should not be viewed in isolation or as alternatives to measures of Siemens Healthineers' net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework. Other companies that report or describe similarly titled alternative performance measures may calculate them differently, and therefore they may not be comparable to those included in this document.

Please find further explanations regarding our financial key performance indicators in chapter "A.2 Financial performance system" and in the notes to the consolidated financial statements note 29 "Segment information" in the Annual Report 2020 of Siemens Healthineers. Additional information is also included in the Quarterly Statement. These documents can be found under the following internet link https://www.siemens- healthineers.com/investor-relations/presentations-financial-publications. As of beginning of fiscal year 2020, Siemens Healthineers applies the accounting standard IFRS 16, Leases. Comparative figures for the preceding fiscal year were not adjusted. Instead, the overall insignificant transition effects were recognized in equity as of October 1, 2019.

Due to rounding, individual numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures to which they refer.

Due to technical reasons, there may be discrepancies in formatting of the accounting data included in this document and made publicly available according to applicable legal rules.

This document is an English language translation of the German document. In case of discrepancies, the German language document is the sole authoritative and universally valid version.

The information contained in this presentation is provided as of the date of this presentation and is subject to change without notice.

2

Unrestricted © Siemens Healthineers, 2021

Imaging

Capital Markets Day 2021

André Hartung

President Diagnostic Imaging

Unrestricted © Siemens Healthineers, 2021

PatientPrecision

Twinning Therapy

Digital, Data and AI

Capital Markets Day 2021 | Imaging

4

Unrestricted © Siemens Healthineers, 2021

Siemens Healthineers is the global leader in imaging

Market positionFinancials FY21Revenue Split FY21

34%

€9.8 bn

Ultrasound

X-ray

6%

Market Share 1

Revenue

Products 14%

Magnetic

35% Resonance

>145k

€2.1 bn

AP

35%

29%

EMEA

Molecular 15%

Adjusted EBIT

Growing installed base

2

AM

Imaging

36%

~26k

21%

31%

Computed

Adjusted EBIT margin

Tomography

Global employee footprint

Most comprehensive and highly innovative portfolio across all relevant segments from value to high-end

1 Magnetic

1 Computed

1 X-ray

1 Molecular

5 Ultra-

Digital

Resonance

Tomography

Products

Imaging

sound

Solutions 3

Services

1 Total addressable market for Imaging with current portfolio (FY2021), excl. Ultrasound | 2 As of FY2021 excl. Ultrasound

Capital Markets Day 2021 | Imaging 5

3 Revenue shown within modality revenue

Unrestricted © Siemens Healthineers, 2021

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Siemens Healthineers AG published this content on 17 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2021 07:06:03 UTC.


ę Publicnow 2021
All news about SIEMENS HEALTHINEERS AG
01/27SIEMENS HEALTHINEERS : Buy rating from Berenberg
MD
01/26Siemens Healthineers Launches Enhanced Liver Fibrosis Test in the U.S
CI
01/26Lockheed Martin Aeronautics adopts Siemens' Xcelerator portfolio to support digital eng..
AQ
01/24SIEMENS HEALTHINEERS AG : Release of a capital market information
EQ
01/21SIEMENS HEALTHINEERS : Goldman Sachs raises its recommendation from Sell to Buy
MD
01/20SIEMENS HEALTHINEERS : Raised to Buy by Jefferies
MD
01/19SIEMENS HEALTHINEERS : Credit Suisse gives a Buy rating
MD
01/18Siemens AG - New strategic owner for Yunex Traffic
AQ
01/17SIEMENS HEALTHINEERS AG : Release of a capital market information
EQ
01/17SIEMENS HEALTHINEERS : Receives a Buy rating from JP Morgan
MD
More news
Analyst Recommendations on SIEMENS HEALTHINEERS AG
More recommendations
Financials
Sales 2022 20 088 M 22 402 M 22 402 M
Net income 2022 1 973 M 2 200 M 2 200 M
Net Debt 2022 11 753 M 13 107 M 13 107 M
P/E ratio 2022 33,1x
Yield 2022 1,65%
Capitalization 64 915 M 72 393 M 72 393 M
EV / Sales 2022 3,82x
EV / Sales 2023 3,55x
Nbr of Employees 66 000
Free-Float -
Chart SIEMENS HEALTHINEERS AG
Duration : Period :
Siemens Healthineers AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SIEMENS HEALTHINEERS AG
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 57,88 €
Average target price 70,71 €
Spread / Average Target 22,2%
EPS Revisions
Managers and Directors
Bernhard Montag Chief Executive Officer
Jochen Schmitz Chief Financial Officer
Ralf Peter Thomas Chairman-Supervisory Board
Thorsten Opderbeck Head-Technology, Trade & Regional Media
A. Gregory Sorensen Member-Supervisory Board
Sector and Competitors